Medical devices, healthcare technology and the business of care
510(k) clearance · K253529

Peerbridge COR MDx (Cor MDx)

Peerbridge Health, Inc. · Decision date Sep 4, 2026

MEDTECHLEDGER EXPLANATIONK253529

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision for Peerbridge COR MDx (Cor MDx), submission K253529, dated September 4, 2026, with a received date of November 13, 2025. The applicant is Peerbridge Health, Inc.; the device falls under 21 CFR 870.2800, product code MWJ, in the cardiovascular specialty, and the review was abbreviated with no third-party review. SESE is a 510(k) clearance, not a premarket approval.

The cleared device is a retrospective ambulatory ECG recorder with a patient-activated event button, recording external ECG for up to fourteen days for manual retrospective review by qualified clinical personnel. The summary states the device performs no automated arrhythmia detection, real-time analysis, or diagnostic interpretation, and is not intended for ST segment analysis, ischemia detection, or myocardial infarction detection. Substantial equivalence is claimed to the Peerbridge Cor System (K171936); the summary describes the same two-channel acquisition, 200 Hz sampling, 16-bit resolution, 0.5–40 Hz response and electrode geometry, with maximum recording duration extended from seven to fourteen days.

The source does not include the full indications enclosure, clinical performance data, or the predicate's complete labeling, so comparative clinical performance cannot be assessed from these records.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Sep 4, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K253529
Regulatory pathway
510(k) premarket notification
Product code
MWJ
Decision code
SESE
Decision date
Sep 4, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Electrocardiograph, Ambulatory (Without Analysis).

Product code
MWJ
FDA device class
2

FDA decision timeline

  1. K253529 received

    Application receipt date recorded by FDA.

  2. K253529 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code MWJ

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Peerbridge Health, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
New York, NY

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records